Offer - Urjas Oil for just ₹ 1 X
Tri Olmesar is a commercial drug that is prescribed in the form of Tablet. Other than this, Tri Olmesar has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Tri Olmesar depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Tri Olmesar include Upper respiratory tract infection. Some other side effects of Tri Olmesar have been listed ahead. Normally, these side effects of Tri Olmesar are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Tri Olmesar's effect during pregnancy is Safe and Safe while nursing. It is important to know if Tri Olmesar has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Tri Olmesar related warnings section.
Tri Olmesar is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) as it can result in adverse effects. Other contraindications of Tri Olmesar have been discussed in the sections ahead.
Additionally, Tri Olmesar may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Tri Olmesar, it is important to know that it is not safe while driving, and is not habit-forming.
Tri Olmesar is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Tri Olmesar safe for pregnant women?
Pregnant women can take Tri Olmesar without worrying about any side effects.
Is the use of Tri Olmesar safe during breastfeeding?
Tri Olmesar is safe for breastfeeding women.
What is the effect of Tri Olmesar on the Kidneys?
Tri Olmesar has very mild side effects on the kidneys.
What is the effect of Tri Olmesar on the Liver?
Tri Olmesar may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Tri Olmesar on the Heart?
Tri Olmesar is rarely harmful for the heart.
Tri Olmesar should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tri Olmesar unless your doctor advises you to do so -
Is this Tri Olmesar habit forming or addictive?
Forming a habit of Tri Olmesar has not been reported.
Interaction between Food and Tri Olmesar
Taking Tri Olmesar with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Tri Olmesar
Consuming Tri Olmesar with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448